Landong, Jaime V.
HRN: 23-54-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2023
CO-AMOXICLAV 625MG (TAB)
08/20/2023
08/27/2023
PO
625mg
TID
Lacerated Wound, Forehead
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes